Gilead Sciences settles patent disputes with Lupin, Cipla and 3 others over HIV, Hepatitis B drugs generic versions
The generic drugmakers argued that the patents were invalid and unenforceable. They said in an August court filing that Gilead's patents covered "routine and predictable" variants of a "compound it...
Source: medicaldialogues.in